{
    "nctId": "NCT02791750",
    "briefTitle": "5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma",
    "officialTitle": "5 Years Follow-up in the Lorraine Institute of Oncology With Adjuvant Therapy for Women With Breast Invasive Carcinoma",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Factors associated with persistence to hormone therapy for breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients following-up in the Lorraine Institute of Oncology at 5 years of the beginning of an adjuvant hormonal therapy\n* Women with breast invasive carcinoma positive-RH and indication of adjuvant hormonal therapy\n* Adult patients\n* Being capable and agree to follow the study procedure\n* Patients informed and non-opposed\n* Covered by social security\n\nExclusion Criteria:\n\n* History of other cancer except basal cell carcinoma\n* Patients with breast invasive carcinoma negative-RH\n* Synchronous metastases\n* Relapsed\n* Previous adjuvant hormonal therapy\n* Men\n* Patients with guardianship",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}